AstraZeneca filed a lawsuit to challenge a new Medicare drug price negotiation p...
Good morning Pharmalittle students. This is Allison DeAngelis, filling in for Ed...
A heart failure study adds to the growing body of data showing that Wegovy has b...
With last fall’s early start to the respiratory virus season still fresh in the ...
“We let people dialyze to live, rather than living to dialyze,” says John Agar i...
Use of generative AI in health care is still new but NYU Langone is embracing br...
Today, AI in health care is splintered at best. There’s a better way.
The AAP and other experts say the systematic review indicates their confidence i...
Does biotech prepare you for the presidency? Who really wants to gut the FDA? An...
Japan has granted a new drug substance patent for BioArctic’s monoclonal antibod...
Dizal has received approval from China’s NMPA for sunvozertinib to treat adult p...
The newly-launched business, called Corvardis, is already targeting the Humira b...
Candidates at the first Republican primary debate diverged on the extent of abor...
The EMA accepted Novaliq’s marketing authorisation application for cyclosporine ...
The companies received a $3.67m grant to develop a low-cost, temperature-stable ...
The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over...
